Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 6Other hematologic neoplasm 4CNS 4Thoracic 3Sarcoma 3Gastrointestinal 2Breast 2Plasma cell 1Other neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Endocrine 1Classical hematology 1

Conditions

Breast Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × DNA Methylation × Breast × Clear all
NCT00899548 2019-07-26

DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Completed
182 enrolled 10 charts
Breast

Breast Neoplasms

NCT00373191 2015-10-12

Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Completed
35 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡